ID: ALA3287209

Max Phase: Preclinical

Molecular Formula: C15H11F3N2O2S

Molecular Weight: 340.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1CSc2cccnc2N1Cc1cccc(OC(F)(F)F)c1

Standard InChI:  InChI=1S/C15H11F3N2O2S/c16-15(17,18)22-11-4-1-3-10(7-11)8-20-13(21)9-23-12-5-2-6-19-14(12)20/h1-7H,8-9H2

Standard InChI Key:  NCPJHYQGWPFKQN-UHFFFAOYSA-N

Associated Targets(Human)

Intermediate conductance calcium-activated potassium channel protein 4 87 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 340.33Molecular Weight (Monoisotopic): 340.0493AlogP: 3.62#Rotatable Bonds: 3
Polar Surface Area: 42.43Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.01CX LogP: 3.63CX LogD: 3.63
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.86Np Likeness Score: -1.69

References

1. Blass B..  (2014)  Fused Thiazin-3-ones as KCa3.1 Inhibitors.,  (5): [PMID:24900861] [10.1021/ml500090s]

Source